Breaking News

Sanofi, GSK, request FDA authorization for traditional, protein-based Covid vaccine

Americans may soon have another Covid vaccine option hitting the market, and it is a more conventional shot people may be more familiar with.

Pharmaceutical giant Sanofi, based in France, and GlaxoSmithKline (GSK), based in the UK, have submitted a joint-application to the Food and Drug Administration (FDA) for authorization for a two-dose COVID-19 vaccine and booster shot.

The shot is a protein-based vaccine, making it similar to the flu shot and other vaccines Americans have received in their youth.

Clinical trials showed promise for the jab as well, showing nearly 60 percent effectiveness at preventing symptomatic Covid infection and 100 percent effectiveness against hospitalization or death caused by the virus.

Like Novavax – which is also seeking authorization for a protein-based…


Read the Full Article Here dailymail

About bourbiza mohamed

Check Also

Video shows penguins refusing cheaper fish as rising inflation forces Japanese aquarium to cut costs

Hilarious reaction of fussy penguins who REFUSE to eat their food at Japanese aquarium after …

Leave a Reply

Your email address will not be published.